- ICH GCP
- Реестр клинических исследований США
- Клиническое испытание NCT07704008
The Effect of Virtual Reality Glasses Applied to Hemodialysis Patients on Vital Signs and Anxiety Level
Обзор исследования
Статус
Условия
Вмешательство/лечение
Подробное описание
The research was designed and conducted as a randomized controlled experimental study to determine the effects of virtual reality glasses on the vital signs and anxiety levels of hemodialysis patients.
The study population consisted of patients diagnosed with kidney failure who received hemodialysis at Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital between May 2023 and May 2024. A total of 56 patients who volunteered to participate and met the inclusion criteria were included in the study. These patients were randomly assigned to two homogeneous groups according to gender and type of renal failure (acute/chronic): an experimental group (n=28) and a control group (n=28).
Patients in the experimental group watched a 4K virtual reality video featuring natural scenery accompanied by relaxing background music through virtual reality glasses during hemodialysis, whereas patients in the control group received standard hemodialysis care without any additional intervention.
Data were collected using the Patient Information Form, Vital Signs Follow-up Form, Visual Analog Scale for Pain (VAS), State Anxiety Scale, and Visual Analog Scale for Satisfaction (VAS-Satisfaction). Ethics committee approval, institutional permission, and written informed consent were obtained before the study was conducted.
Тип исследования
Регистрация (Действительный)
Фаза
- Непригодный
Контакты и местонахождение
Места учебы
-
-
-
Ankara, Турция (Туркие), 06200
- Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
-
-
Критерии участия
Критерии приемлемости
Возраст, подходящий для обучения
- Взрослый
- Пожилой взрослый
Принимает здоровых добровольцев
Описание
Inclusion Criteria:
- Receiving hemodialysis treatment for the first time.
- Age ≥18 years.
- No visual, hearing, or cognitive impairment.
- Able to communicate effectively.
- Clinically stable.
- No diagnosed psychiatric disorder or use of psychiatric medication.
- No history of seizures.
- Willing and able to provide informed consent.
Exclusion Criteria:
- Previous hemodialysis treatment.
- Age <18 years.
- Visual, hearing, or cognitive impairment.
- History of kidney transplantation.
- Communication difficulties.
- Diagnosed psychiatric disorder or use of psychiatric medication.
- History of seizures.
- Declined to participate in the study.
Учебный план
Как устроено исследование?
Детали дизайна
- Основная цель: Поддерживающая терапия
- Распределение: Рандомизированный
- Интервенционная модель: Параллельное назначение
- Маскировка: Нет (открытая этикетка)
Оружие и интервенции
Группа участников / Армия |
Вмешательство/лечение |
|---|---|
|
Экспериментальный: Experimental Group
Participants received a virtual reality intervention during hemodialysis in addition to standard care.
|
Participants wore virtual reality glasses at the start of the hemodialysis session and viewed a 4K nature video with calming background music for 15 minutes.
The intervention was administered once during the hemodialysis session in addition to standard hemodialysis care.
Participants received routine hemodialysis care according to the standard clinical practice of the dialysis unit without any additional intervention.
|
|
Активный компаратор: Control Group
Participants received standard hemodialysis care without any additional intervention.
|
Participants received routine hemodialysis care according to the standard clinical practice of the dialysis unit without any additional intervention.
|
Что измеряет исследование?
Первичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Change in Systolic Blood Pressure
Временное ограничение: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
Change in systolic blood pressure measured before and after the hemodialysis session.
|
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
|
Change in Diastolic Blood Pressure
Временное ограничение: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
Change in diastolic blood pressure measured before and after the hemodialysis session.
|
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
|
Change in Heart Rate
Временное ограничение: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
Change in heart rate measured before and after the hemodialysis session.
|
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
|
Change in Respiratory Rate
Временное ограничение: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
Change in respiratory rate measured before and after the hemodialysis session.
|
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
|
Change in Peripheral Oxygen Saturation (SpO₂)
Временное ограничение: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
Change in peripheral oxygen saturation (SpO₂) measured before and after the hemodialysis session.
|
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
|
Change in Body Temperature
Временное ограничение: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
Change in body temperature measured before and after the hemodialysis session.
|
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
|
State Anxiety Level After Hemodialysis
Временное ограничение: Immediately after completion of the hemodialysis session.
|
State anxiety measured using the State Anxiety Inventory (STAI-State), a 20-item questionnaire with total scores ranging from 20 to 80. Higher scores indicate greater levels of state anxiety.
Assessment was performed immediately after completion of the hemodialysis session.
|
Immediately after completion of the hemodialysis session.
|
Вторичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Change in Pain Score
Временное ограничение: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
Change in pain score measured using the Visual Analog Scale for Pain (VAS-P), a 0-10 scale where 0 indicates no pain and 10 indicates the worst possible pain.
Higher scores indicate greater pain.
Pain was assessed before and immediately after completion of the hemodialysis session.
|
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
|
Participant Satisfaction Score
Временное ограничение: Immediately after completion of the hemodialysis session.
|
Participant satisfaction with the virtual reality intervention measured using the Visual Analog Scale for Satisfaction (VAS-S), a 0-10 scale where 0 indicates not satisfied at all and 10 indicates completely satisfied.
Higher scores indicate greater participant satisfaction.
Assessment was performed immediately after completion of the hemodialysis session.
|
Immediately after completion of the hemodialysis session.
|
Соавторы и исследователи
Следователи
- Директор по исследованиям: Hilal Tüzer, Assoc. Prof., Ankara Yildirim Beyazıt University
Даты записи исследования
Изучение основных дат
Начало исследования (Действительный)
Первичное завершение (Действительный)
Завершение исследования (Действительный)
Даты регистрации исследования
Первый отправленный
Впервые представлено, что соответствует критериям контроля качества
Первый опубликованный (Действительный)
Обновления учебных записей
Последнее опубликованное обновление (Действительный)
Последнее отправленное обновление, отвечающее критериям контроля качества
Последняя проверка
Дополнительная информация
Термины, связанные с этим исследованием
Ключевые слова
Дополнительные соответствующие термины MeSH
Другие идентификационные номера исследования
- AYBU-2023-208
Планирование данных отдельных участников (IPD)
Планируете делиться данными об отдельных участниках (IPD)?
Описание плана IPD
Информация о лекарствах и устройствах, исследовательские документы
Изучает лекарственный продукт, регулируемый FDA США.
Изучает продукт устройства, регулируемый Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов США.
Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .